Loading insider details...
Beta
Latest Form 4 (Jan 8, 2026): Sale of 3,573 RNAC shares, $24.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 8, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Sale | 3,573 | $24.4K |
| Jan 6, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 27,000 | n/a |
| Jan 8, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Sale | 932 | $15.6K |
| Jan 6, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 19,000 | n/a |
| Nov 19, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Exercise/Conversion | 35,000 | $113.0K |
| Apr 11, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Exercise/Conversion | 2,566 | n/a |
| Jan 4, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 548,200 | n/a |
| Nov 15, 2023 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,566 | n/a |